GILD Archives - Page 14 of 29

3 minute read

News

Center For Disease Analysis Foundation Announces Receipt Of An $8M Grant From Gilead Sciences To Relink Hepatitis B And C Patients To Care In The U.S.

July 20, 12:01 PM

The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (NASDAQ:GILD) as part of Gilead's Relink grant program. CDA Foundation

GILD

2 minute read

Peering Into Gilead Sciences’s Recent Short Interest

By Benzinga Insights

July 19, 12:45 PM

Gilead Sciences’s (NYSE:GILD) short percent of float has risen 6.16% since its last report. The company recently reported…

GILD

1 minute read

Price Over Earnings Overview: Gilead Sciences

By Benzinga Insights

July 17, 4:00 PM

In the current market session, Gilead Sciences Inc. (NASDAQ:GILD) share price is at $77.52, after a 0.42% spike.…

GILD

2 minute read

FDA Approves Gilead’s Remdesivir For COVID-19 Treatment Patients With Severe Renal Impairment

By Vandana Singh

July 14, 11:23 AM

The FDA approved Gilead Sciences Inc's (NASDAQ: GILD) supplemental new drug application for using Veklury (remdesivir) in COVID-19 patients with severe renal impairment,

GILD